Nantes University Hospital
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1503-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.chu-nantes.fr
Pain Catastrophizing and Routine Assessment of Patient Index Data 3(RAPID3) in Ten Categories of Rheumatology Outpatients
Completed
- Conditions
- Arthritis, RheumatoidSpondyloarthritisInflammatory RheumatismsSystemic Disorders
- First Posted Date
- 2017-10-11
- Last Posted Date
- 2021-09-21
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 572
- Registration Number
- NCT03306784
- Locations
- 🇫🇷
CHU de Nantes, Nantes, France
Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis
Completed
- Conditions
- Relapsing-remitting Multiple Sclerosis
- First Posted Date
- 2017-10-05
- Last Posted Date
- 2017-10-05
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 3000
- Registration Number
- NCT03302442
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, France
Mitochondrial Metabolism and Hepatic Complications of Obesity
Not Applicable
Withdrawn
- Conditions
- Obesity
- Interventions
- Other: liver biopsy
- First Posted Date
- 2017-10-05
- Last Posted Date
- 2021-08-24
- Lead Sponsor
- Nantes University Hospital
- Registration Number
- NCT03302481
Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis
Completed
- Conditions
- Progressive Multiple Sclerosis
- First Posted Date
- 2017-10-05
- Last Posted Date
- 2021-09-21
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 103
- Registration Number
- NCT03302806
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, France
Impact of the Nurse Visit on Observance of the Intake of Oral Carcinological Treatment in the Elderly
Not Applicable
Terminated
- Conditions
- Oncology, Gerontology
- Interventions
- Other: nursing visitOther: no nursing visit
- First Posted Date
- 2017-10-03
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 61
- Registration Number
- NCT03300310
- Locations
- 🇫🇷
CHD Vendée, La Roche-sur-Yon, France
🇫🇷ICO Angers, Angers, France
🇫🇷CH Saint Nazaire, Saint Nazaire, France
Post Pancreatitis Complications Study (Based on a Prospective Data Base)
Withdrawn
- Conditions
- Pancreatitis
- Interventions
- Other: Collection of medical datas from ICU patients
- First Posted Date
- 2017-09-15
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- Nantes University Hospital
- Registration Number
- NCT03284489
- Locations
- 🇫🇷
Poitiers University Hospital, Poitiers, France
🇫🇷Rennes University Hospital, Rennes, France
🇫🇷Tours University Hospital, Tours, France
Post Surgically Treated Peritonitis Complications
Withdrawn
- Conditions
- Peritonitis
- Interventions
- Other: Collection of medical data from ICU patients
- First Posted Date
- 2017-09-15
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- Nantes University Hospital
- Registration Number
- NCT03284476
- Locations
- 🇫🇷
Poitiers University Hospital, Poitiers, France
🇫🇷Angers University Hospital, Angers, France
🇫🇷Nantes University Hospital, Nantes, France
Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery
Not Applicable
Recruiting
- Conditions
- Mitral Regurgitation
- Interventions
- Procedure: cardiac surgeryDevice: percutaneous mitral valve repair with MITRACLIP NT, MITRACLIP NTR/XTR, MITRACLIP G4NT/XT, MITRACLIP G4NTW/XTW
- First Posted Date
- 2017-09-05
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 330
- Registration Number
- NCT03271762
- Locations
- 🇫🇷
Chu Bordeaux, Bordeaux, France
🇫🇷Clinique Saint Augustin, Bordeaux, France
🇫🇷Chru Brest, Brest, France
Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC
Phase 2
Terminated
- Conditions
- Graft Versus Host Disease
- Interventions
- Drug: FludarabineDrug: ClofarabineRadiation: Full body irradiationDrug: CyclophosphamideOther: stem cell transplantationOther: nuclear cellsDrug: Thymoglobulin Injectable Product
- First Posted Date
- 2017-08-28
- Last Posted Date
- 2022-07-15
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 47
- Registration Number
- NCT03263767
- Locations
- 🇫🇷
Nantes Uh, Nantes, France
PancRea: Risk Factors and Outcomes of Infected Pancreatic Necrosis
Completed
- Conditions
- InfectionAcute Necrotizing PancreatitisPancreatitis
- Interventions
- Other: No intervention
- First Posted Date
- 2017-08-18
- Last Posted Date
- 2017-08-18
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 148
- Registration Number
- NCT03253861
© Copyright 2025. All Rights Reserved by MedPath